Marie A. Chisholm-Burns, PharmD, PhD, MPH, MBA, FCCP, FASHP, FAST, executive vice president and provost at Oregon Health and Science University, is receiving the award, which is presented to individuals who demonstrate excellence in pharmacy practice leadership.
Over the decades, the American Society of Health-System Pharmacists (ASHP) has been there during the career of Marie A. Chisholm-Burns, PharmD, PhD, MPH, MBA, FCCP, FASHP, FAST.
At this year’s ASHP Midyear Clinical Meeting & Exposition, Chisholm-Burns, executive vice president and provost at Oregon Health and Science University, will be receiving the ASHP Board of Directors’ Distinguished Leadership Award for her work in pharmacy practice leadership and academic pharmacy.
Transcript
What is the ASHP Board of Directors’ Distinguished Leadership Award, and what work have you done leading to you receiving this award at the 2023 ASHP Midyear Clinical Meeting & Exposition?
First, I want to thank ASHP Board of Directors for selecting me for the Distinguished Leadership Award. The award, to my understanding, is for individuals who have excellence in pharmacy practice leadership. I've done several things not only in pharmacy practice, but also in pharmacy practice leadership, including academic pharmacy, so I'm just honored.
ASHP is an organization that really means a lot to me. It's probably been there since the beginning with [my] residency training. I don't want to age myself here, but it's been decades that we have been friends and on this journey together. I also had the honor of being the founding chair, and now the past chair of the ASHP's new Section of Pharmacy Educators. And so that means a lot to me. It means a lot that ASHP has asked me to be involved in several things over the years.
So, that's a little bit about the award. I'm looking forward to receiving the award. My husband, John, is going to be there. And I'm just looking forward to seeing people again. I’m very excited about many things. Life is good.
Inside the Center's MDD Value Model and Its Use of Dynamic Pricing
May 13th 2025Larragem Raines, MS, of the Center for Innovation & Value Research, discusses the organization's major depressive disorder (MDD) open-source value model, dynamic pricing, and the future role of artificial intelligence in care.
Listen
Lower Risk of Cardiovascular Events With Acalabrutinib vs Ibrutinib in CLL in Real-World Study
May 17th 2025The real-world data showed lower rates of atrial fibrillation and hypertension associated with the second-generation Bruton tyrosine kinase inhibitor among patients with chronic lymphocytic leukemia (CLL).
Read More